| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 12 securities · passive | ||||||
|
Tenax Therapeutics, Inc.
13G/A
TENX · 88032L605
|
0.8% |
5/15/2026
Event 3/31/2026
|
||||
| Lind Global Fund II LP | 0.8% | |||||
| Lind Global Partners II LLC | 0.8% | |||||
| Easton Jeff | 0.8% | |||||
|
Golden Minerals Co
13G/A
AUMN · 381119403
|
8.7% |
8/13/2025
Event 6/30/2025
|
||||
| Lind Global Fund II LP | 8.7% | |||||
| Lind Global Partners II LLC | 8.7% | |||||
| Easton Jeff | 8.7% | |||||
|
Webuy Global Ltd
13G/A
WBUYF · G9513S102
|
0% |
8/13/2025
Event 6/30/2025
|
||||
| Lind Global Fund II LP | 0% | |||||
| Lind Global Partners II LLC | 0% | |||||
| Easton Jeff | 0% | |||||
|
ABVC Biopharma, Inc.
13G/A
ABVC · 00091F304
|
3.2% |
8/13/2025
Event 6/30/2025
|
||||
| Lind Global Fund II LP | 3.2% | |||||
| Lind Global Partners II LLC | 3.2% | |||||
| Easton Jeff | 3.2% | |||||
|
Lifeward Ltd.
13G/A
LFWD · M8216Q200
|
1.7% |
5/15/2025
Event 3/31/2025
|
||||
| Lind Global Fund II LP | 1.7% | |||||
| Lind Global Partners II LLC | 1.7% | |||||
| Easton Jeff | 1.7% | |||||
|
SINTX Technologies, Inc.
13G/A
SINT · 829392703
|
2.8% |
5/15/2025
Event 3/31/2025
|
||||
| Lind Global Fund II LP | 2.8% | |||||
| Lind Global Partners II LLC | 2.8% | |||||
| Easton Jeff | 2.8% | |||||
|
Netcapital Inc.
13G/A
NCPL · 64113L202
|
4.9% |
5/15/2025
Event 3/31/2025
|
||||
| Lind Global Fund II LP | 4.9% | |||||
| Lind Global Partners II LLC | 4.9% | |||||
| Easton Jeff | 4.9% | |||||
|
SenesTech, Inc.
13G/A
SNES · 81720R604
|
4.9% |
5/15/2025
Event 3/31/2025
|
||||
| Lind Global Fund II LP | 4.9% | |||||
| Lind Global Partners II LLC | 4.9% | |||||
| Easton Jeff | 4.9% | |||||
|
Seelos Therapeutics, Inc.
13G/A
SEELQ · 81577F406
|
0% |
2/14/2025
Event 12/31/2024
|
||||
| Lind Global Fund II LP | 0% | |||||
| Lind Global Partners II LLC | 0% | |||||
| Lind Global Asset Management V, LLC | 0% | |||||
| Easton Jeff | 0% | |||||
|
GSE Systems, Inc.
13G/A
GVP · 36227K205
|
0% |
2/14/2025
Event 12/31/2024
|
||||
| Lind Global Fund II LP | 0% | |||||
| Lind Global Partners II LLC | 0% | |||||
| Easton Jeff | 0% | |||||
|
PaxMedica, Inc.
13G/A
PXMD · 70424C203
|
9.9% |
2/14/2025
Event 12/31/2024
|
||||
| Lind Global Fund II LP | 9.9% | |||||
| Lind Global Partners II LLC | 9.9% | |||||
| Easton Jeff | 9.9% | |||||
|
NLS Pharmaceuticals Ltd.
13G/A
NLSP · H57830137
|
4.9% |
2/14/2025
Event 12/31/2024
|
||||
| Lind Global Fund II LP | 4.9% | |||||
| Lind Global Partners II LLC | 4.9% | |||||
| Easton Jeff | 4.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.